Yang Luo - Cancer Institute and Hospital, Chinese Academy of Medical Sciences

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 136 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

The Ideal Strategies of Antibody‒drug Conjugate Sequential Treatment in HER2-expressing Metastatic Breast Cancer: A Multi-Center Real-World Study

Xuenan Peng,Bo Lan,Jiayu Wang,Qiao Li,Jiani Wang,Ying Fan,Yang Luo,Shanshan Chen,Hongnan Mo,Lixi Li, Xiaoying Sun, Jintao Zhang,Ruigang Cai,Pin Zhang,Binghe Xu,Fei Ma

Breast (Edinburgh, Scotland)（2025）

Cited0Views0WOSBibtex

Safety and Efficacy of PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Combination Therapy in Patients with Advanced Hepatocellular Carcinoma Combined with Hyperbilirubinemia: a Retrospective Cohort Study

Shida Pan, Jianing Wang, Jiahe Tian, Yilin Wang,Siyu Wang, Yingying Yu,Fengyi Li,Yan-Mei Jiao, Yingjuan Shen,Luo Yang, Xiaomeng Liu,Qin Qiu, Junqing Luan,Fu-Sheng Wang,Fanping Meng

Frontiers in immunology (2025): 1530477-1530477

Cited0Views0WOSBibtex

Comparative Efficacy of Anthracycline-Free and Anthracycline-Containing Neoadjuvant Chemoimmunotherapy Regimens for Triple-Negative Breast Cancer

Yuhan Wei,Qiao Li,Hongnan Mo, Yalong Qi,Hewei Ge,Xiaoying Sun,Ying Fan,Pin Zhang,Jiayu Wang,Yang Luo,Jing Wang,Fei Ma

TRANSLATIONAL ONCOLOGY (2025)

Cited0Views0WOSBibtex

Lerociclib Plus Fulvestrant in Patients with HR+/HER2− Locally Advanced or Metastatic Breast Cancer Who Have Progressed on Prior Endocrine Therapy: LEONARDA-1 a Phase III Randomized Trial

Binghe Xu,Qingyuan Zhang,Yang Luo,Zhongsheng Tong,Tao Sun,Changping Shan,Xinlan Liu,Yumin Yao, Bing Zhao,Shusen Wang,Xiaohua Zeng,Changlu Hu,Xi Yan,Xiaojia Wang,Hongyan Jia,Zhendong Chen,Fuming Qiu,Xinhong Wu, Deyong Zhang, Tong Li

Nature Communicationsno. 1 (2025): 1-9

Cited0Views0WOSNATUREBibtex

Clinicopathological Factors That Predict Different Responses of Breast and Axillary Tumors to Neoadjuvant Chemotherapy and Prognosis among Patients with Node-Positive Breast Cancer: Real World Data

Danyang Ji,Bo Lan,Jiayu Wang,Fei Ma,Yang Luo,Qing Li,Pin Zhang,Ruigang Cai,Qiao Li,Shanshan Chen,Binghe Xu,Ying Fan

Thoracic cancerno. 7 (2025): e70035-e70035

Cited0Views0WOSBibtex

PathoHR: Breast Cancer Survival Prediction on High-Resolution Pathological Images

Yang Luo, Shiru Wang,Jun Liu, Jiaxuan Xiao, Rundong Xue, Zeyu Zhang,Hao Zhang, Yu Lu,Yang Zhao,Yutong Xie

arxiv（2025）

Cited0Views0Bibtex

Major Pathologic Response and Long-Term Clinical Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer after Neoadjuvant Chemotherapy

Lei Ji,Xi Chen,Xiaoyan Qian,Min Xiao,Qing Li,Qiao Li,Jiayu Wang,Ying Fan,Yang Luo,Shanshan Chen,Fei Ma,Binghe Xu,Pin Zhang

The Breast（2024）

Cited0Views0WOSBibtex

The Different Sequences of Cdk4/6 Inhibitor and Mtor Inhibitor in Hr+/Her2- Advanced Breast Cancer: A Multicenter Real-World Study

Yuqian Liao,Yujing Tan, Yipeng Li,Fei Ma,Jiayu Wang,Pin Zhang,Qing Li,Qiao Li,Yang Luo,Bo Lan,Shanshan Chen,Binghe Xu,Hanfang Jiang,Weihong Zhao,Ying Fan

Heliyon（2024）

Cited0Views0WOSBibtex

Evolution and Prognostic Significance of HER-2 Conversion from Primary to Residual Disease in HER-2 Negative Patients with Breast Cancer after Neoadjuvant Chemotherapy

Xi Chen, Lei Ji,Xiaoyan Qian,Min Xiao,Qing Li,Jiayu Wang,Ying Fan,Yang Luo,Bo Lan, Shanshan Chen,Fei Ma,Binghe Xu,Pin Zhang

American Journal of Cancer Researchno. 8 (2024): 3859-3872

Cited0Views0WOSBibtex

Subdivision of M1 Category and Prognostic Stage for De Novo Metastatic Breast Cancer to Enhance Prognostic Prediction and Guide the Selection of Locoregional Therapy

Lei Ji, Ge Song,Min Xiao,Xi Chen,Qing Li,Jiayu Wang,Ying Fan,Yang Luo,Qiao Li,Shanshan Chen,Fei Ma,Binghe Xu,Pin Zhang

Thoracic Cancer (2024)

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn